Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4015848 | 0.92 | HRH3 (0.64) | HRH3CYP2D6 | |
| SCHEMBL4020519 | 0.91 | HRH3 (0.61) | HRH3CYP2D6 | |
| SCHEMBL4015702 | 0.86 | HRH3 (0.66) | HRH3CYP2D6 | |
| SCHEMBL3647741 | 0.86 | HRH3 (0.50) | HRH3CYP2D6 | |
| SCHEMBL3645815 | 0.86 | HRH3 (0.49) | HRH3CYP2D6 | |
| SCHEMBL3646985 | 0.85 | HRH3 (0.54) | HRH3CYP2D6 | |
| SCHEMBL3646987 | 0.85 | HRH3 (0.54) | HRH3CYP2D6 | |
| SCHEMBL4021042 | 0.84 | HRH3 (0.53) | HRH3CYP2D6 | |
| SCHEMBL3693049 | 0.84 | HRH3 (0.51) | HRH3CYP2D6 | |
| SCHEMBL3641929 | 0.84 | HRH3 (0.55) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534788-B2 | Benzofuran and benzothiophene-2-carboxylic acid amide derivatives | HOFFMANN-LA ROCHE INC. (US) | 2009-05-19 | — | — | US | disclosed |
| US-20090029976-A1 | BENZOFURAN AND BENZOTHIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES | HOFFMANN-LA ROCHE, INC. | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090029976-A1 | BENZOFURAN AND BENZOTHIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES | HCAR2, HCAR1, HRH3 | HRH3 3/4885CYP2D6 758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.